Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...

British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...

It’s January, which is typically when many of us are looking into shedding some pounds. We’ve been hearing a lot about how ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

Donald Trump joked in his last call with Sir Keir Starmer about coyotes needing weight-loss drugs after becoming fat feasting ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...